cytokinetics

heart money
Biotech

Cytokinetics’ ph. 3 cardio win sends stock soaring

Aficamten bested a standard-of-care beta blocker in a phase 3 heart disease test, bolstering the asset's blockbuster expectations.
Darren Incorvaia Sep 2, 2025 2:05pm
yellow light street light traffic pause slow delay

FDA pushes back Cytokinetics' heart drug PDUFA to year-end

May 2, 2025 7:48am
scoop of pink ice cream

Sanofi scoops up China rights to Cytokinetics' heart disease med

Dec 20, 2024 11:07am
heart

Edgewise unveils promising early data for heart disease drug

Sep 20, 2024 4:00am
unhappy angry mad sad alone smile emotions

Investors say 'no bueno' to Cytokinetics' complex Royalty deal

May 23, 2024 10:36am
photo of a royal flush laid out on the poker table with chips scattered nearby

Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos

May 13, 2024 9:36am